BNP Paribas Financial Markets’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-428
| Closed | -$116 | – | 4952 |
|
|
2022
Q3 | $116 | Hold |
428
| – | – | ﹤0.01% | 4638 |
|
|
2022
Q2 | $330 | Sell |
428
-4
| -0.9% | -$4 | ﹤0.01% | 3969 |
|
|
2022
Q1 | $462 | Sell |
432
-17,419
| -98% | -$31.7K | ﹤0.01% | 4023 |
|
|
2021
Q4 | $33.9K | Buy |
17,851
+17,359
| +3,528% | +$41.6K | ﹤0.01% | 3802 |
|
|
2021
Q3 | $1.48K | Buy |
492
+74
| +18% | +$264 | ﹤0.01% | 3837 |
|
|
2021
Q2 | $1.63K | Sell |
418
-15,669
| -97% | -$65K | ﹤0.01% | 3904 |
|
|
2021
Q1 | $81.6K | Buy |
16,087
+11,137
| +225% | +$57.8K | ﹤0.01% | 3441 |
|
|
2020
Q4 | $20.2K | Sell |
4,950
-632
| -11% | -$3.1K | ﹤0.01% | 3847 |
|
|
2020
Q3 | $27.1K | Buy |
5,582
+4,705
| +536% | +$25.7K | ﹤0.01% | 3726 |
|
|
2020
Q2 | $4.86K | Buy |
877
+875
| +43,750% | +$4.01K | ﹤0.01% | 4017 |
|
|
2020
Q1 | $7 | Hold |
2
| – | – | ﹤0.01% | 4291 |
|
|
2019
Q4 | $9 | Sell |
2
-1
| -33% | -$3 | ﹤0.01% | 4396 |
|
|
2019
Q3 | $12 | Hold |
3
| – | – | ﹤0.01% | 4483 |
|
|
2019
Q2 | $11 | Hold |
3
| – | – | ﹤0.01% | 4510 |
|
|
2019
Q1 | $13 | Sell |
3
-496
| -99% | -$1.73K | ﹤0.01% | 4251 |
|
|
2018
Q4 | $1.24K | Hold |
499
| – | – | ﹤0.01% | 3895 |
|
|
2018
Q3 | $3.64K | Hold |
499
| – | – | ﹤0.01% | 4157 |
|
|
2018
Q2 | $1.85K | Hold |
499
| – | – | ﹤0.01% | 4265 |
|
|
2018
Q1 | $1.92K | Hold |
499
| – | – | ﹤0.01% | 4099 |
|
|
2017
Q4 | $1.8K | Hold |
499
| – | – | ﹤0.01% | 4085 |
|
|
2017
Q3 | $1.97K | Hold |
499
| – | – | ﹤0.01% | 4065 |
|
|
2017
Q2 | $2.54K | Sell |
499
-5
| -1% | -$28 | ﹤0.01% | 4082 |
|
|
2017
Q1 | $3.48K | Buy |
504
+347
| +221% | +$2.71K | ﹤0.01% | 3391 |
|
|
2016
Q4 | $1.47K | Sell |
157
-706
| -82% | -$6.36K | ﹤0.01% | 3976 |
|
|
2016
Q3 | $8.44K | Buy |
863
+361
| +72% | +$4.87K | ﹤0.01% | 3253 |
|
|
2016
Q2 | $7.09K | Buy |
502
+206
| +70% | +$3.21K | ﹤0.01% | 3090 |
|
|
2016
Q1 | $4.14K | Sell |
296
-1,498
| -84% | -$22K | ﹤0.01% | 2306 |
|
|
2015
Q4 | $36.6K | Sell |
1,794
-24
| -1% | -$370 | ﹤0.01% | 3017 |
|
|
2015
Q3 | $23.9K | Buy |
1,818
+1,086
| +148% | +$18K | ﹤0.01% | 3256 |
|
|
2015
Q2 | $11.2K | Buy |
732
+596
| +438% | +$11.4K | ﹤0.01% | 3307 |
|
|
2015
Q1 | $2.72K | Buy |
+136
| New | +$3.04K | ﹤0.01% | 3411 |
|
|
2014
Q4 | – | Sell |
-187
| Closed | -$3.48K | – | 3418 |
|
|
2014
Q3 | $3.48K | Buy |
+187
| New | +$3.39K | ﹤0.01% | 3888 |
|
BNP Paribas Financial Markets's AGTC Position: Q4 2022 in Review
BNP Paribas Financial Markets sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 428 shares — an estimated $116 sold.
BNP Paribas Financial Markets first reported a position in AGTC in Q3 2014 and held it in 32 quarters. The position peaked at $81.6K in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- BNP Paribas Financial Markets reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 428 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $116.
- BNP Paribas Financial Markets first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 32 quarters.
- BNP Paribas Financial Markets's Applied Genetic Technologies Corporation position peaked at $81.6K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.